Institution
Institut de Cancérologie de Lorraine
Also known as: ICL
- 61running trials
- 30closed trials
- 2,013publications (OpenAlex)
Running trials
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)
Recruiting
Recruiting
Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and Attention
Recruiting
Recruiting
Recruiting
Recruiting
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)
Recruiting
Recruiting
Recruiting
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Recruiting
Active, not recruiting
Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer Patients
Active, not recruiting
Recruiting
Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
Recruiting
Active, not recruiting
Recruiting
Recruiting
Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS Study
Recruiting
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Active, not recruiting
Recruiting
Active, not recruiting
Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer
Recruiting
Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic Signal
Active, not recruiting
Active, not recruiting
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
Active, not recruiting
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
Active, not recruiting
Showing 50 of 61.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Head and neck cancer8 recruiting
- Lung cancer8 recruiting
- Colorectal cancer6 recruiting
- Metastatic breast cancer5 recruiting
- Sarcoma5 recruiting
- Childhood cancers4 recruiting
- Kidney cancer3 recruiting
- Pancreatic cancer3 recruiting
- Endometrial cancer2 recruiting
- Neuroendocrine tumours2 recruiting
- Prostate cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Brain metastases1 recruiting
- Cervical cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Mesothelioma1 recruiting
- Neuroblastoma1 recruiting
- Ovarian cancer1 recruiting
- Testicular cancer1 recruiting
- Thymoma and thymic carcinoma1 recruiting
Closed trials
Terminated
Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab
Terminated
Completed
Adherence to Oral Therapies in Advanced Breast and Prostate Cancers
Completed
Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution
Completed
Recruiting
Terminated
Completed
Completed
Study of Combined VisioCyt Test and FGFR3 Mutations on a Urinary Sample to Diagnose Bladder Tumors
Completed
Terminated
Terminated
Completed
Terminated
Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer
Completed
Completed
Completed
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology
Completed
Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases
Completed
Completed
Completed
Completed
Terminated
Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists
Completed
Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer
Completed
Completed
Completed
Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Completed
Completed
Androgen Deprivation Therapy in Advanced Salivary Gland Cancer
Registry name variants (26)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, 54519
59 trials
Institut de cancérologie de Lorraine
Nancy, 54519
12 trials
Institut de Cancérologie de Lorraine (ICL)
Vandoeuvre-lès-nancy, 54519
4 trials
Institut de Cancérologie de Lorraine (ICL)
Vandœuvre-lès-Nancy, 54500
2 trials
Institut de Cancérologie de Lorraine - Nancy
Vandœuvre-lès-Nancy, 54519
2 trials
Contact: Mathilde CUENIN, MD
Contact: Romina MASTRONICOLA, M
Institute de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, Meurthe-et-Moselle 54500
2 trials
Vandoeuvre-lès-Nancy - Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy
2 trials
Contact: Dr Christelle CLEMENT-DUCHENE
Contact: Christelle CLEMENT-DUCHENE
Institut Cancérologie de Lorraine
Vandœuvre-lès-Nancy
1 trial
Institut de Cancérologie de la Lorraine
Nancy, 54519
1 trial
Institut de Cancérologie de Lorraine - Centre Alexis Vautrin
Vandœuvre-lès-Nancy
1 trial
NCT03745950UTOLA: UTerin OLAparib
Institut de Cancérologie de Lorraine (CLCC) Nancy
Vandœuvre-lès-Nancy, Vandœuvre-lès-Nancy Cedex 54519
1 trial
Institut De Cancerologie De Lorraine (Site 0222)
Vandœuvre-lès-Nancy, Ain 54519
1 trial
Institut De Cancerologie De Lorraine (Site 0758)
Vandœuvre-lès-Nancy, 54500
1 trial
Institut De Cancerologie De Lorraine (Site 1010)
Vandœuvre-lès-Nancy, Ain 54519
1 trial
Institut De Cancerologie De Lorraine (Site 3204)
Vandœuvre-lès-Nancy, Ain 54519
1 trial
Institut de Cancérologie lorraine
Vandœuvre-lès-Nancy
1 trial
NCT03293563UroCCR Database: French Research Network for Kidney Cancer -UroCCR
Contact: Sophie MARTIN, Dr
Service de Chirurgie Digestive,Institut de Cancérologie de Lorraine
Nancy
1 trial
Institut de Cancérologie de Lorraine - Service d'Oncologie
Vandœuvre-lès-Nancy
Institut de Cancérologie de Lorraine - Service d'oncologie médicale
Vandœuvre-lès-Nancy
Institut De Cancerologie De Lorraine (Site 1204)
Vandœuvre-lès-Nancy, Ain 54519
Institut De Cancerologie De Lorraine (Site 1409)
Vandœuvre-lès-Nancy, Ain 54519
Institut De Cancerologie De Lorraine (Site 2072)
Vandœuvre-lès-Nancy, Ain 54519
Institut De Cancerologie De Lorraine (Site 5204)
Vandœuvre-lès-Nancy, Meurthe-et-Moselle 54513
Institute de Cancerologie de Lorraine - Nancy
Vandœuvre-lès-Nancy
Nancy - Institut de Cancérologie de Lorraine
Nancy
Privé - Institut de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, 54519
Conditions
Diseases this institution publishes on or runs trials for.
- Metastatic breast cancer18 works · 11 trials
- Head and neck cancer11 works · 12 trials
Institution data: ROR 00yphhr71 (CC0-1.0)Updated 15 Nov 2026